Entrada Therapeutics (TRDA) Revenue (2023 - 2026)
Entrada Therapeutics (TRDA) reported Revenue of $898,000 for Q2 2026, down 53.9% from $1.95 million a year earlier but up 2.6% from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) Revenue (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Entrada Therapeutics' Revenue came in at $4.69 million, down 94.1% year-over-year; for FY2025, it came in at $25.42 million, down 87.9% from FY2024.
- By year, Revenue came in at $210.78 million in FY2024 (+63.4%) and $129.01 million in FY2023.
- Five-year quarterly Revenue spans a low of $875,000 in Q1 2026 and a high of $94.69 million in Q2 2024.
- Year over year, Revenue has now declined in each of the last eight quarters, with an average decline of 70.9% over the last eight quarters.
- The high point for year-over-year Revenue in five years was Q2 2024 (growth of 421.2%); the low point was Q2 2025 (a decline of 97.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $875,000 (Q1 2026), $1.3 million (Q4 2025) and $1.61 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 24.40 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 17.40 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 18.09 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 15.07 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 16.58 Bn |
| 10 | Entrada Therapeutics | 205.54 Mn | -172.82 Mn | - | 905,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 905,000.00 |
| Jun 30, 2026 | 898,000.00 |
| Mar 31, 2026 | 875,000.00 |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.61 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 20.56 Mn |
| Dec 31, 2024 | 37.40 Mn |
| Sep 30, 2024 | 19.57 Mn |
| Jun 30, 2024 | 94.69 Mn |
| Mar 31, 2024 | 59.12 Mn |
| Dec 31, 2023 | 41.85 Mn |
| Sep 30, 2023 | 43.74 Mn |
| Jun 30, 2023 | 18.17 Mn |
| Mar 31, 2023 | 25.26 Mn |
API Access
Entrada Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();